Press releases

Un nouveau traitement en essai clinique chez un premier enfant achondroplase en France

Press release | 09 Apr 2021 - 14h00 | By INSERM PRESS OFFICE
Genetics, genomics and bioinformatics

 

TO CITE THIS POST :
Press release – Inserm press room Un nouveau traitement en essai clinique chez un premier enfant achondroplase en France Link : https://presse.inserm.fr/en/un-nouveau-traitement-entre-en-essai-clinique-chez-un-premier-enfant-achondroplase-en-france/42645/

Other contents In the same category :

Genetics, genomics and bioinformatics Voir tout

communi

The Placenta Could Retain a Memory of Tobacco Exposure Prior to Pregnancy

A study is showing for the first time that tobacco consumption, even when stopped before pregnancy, can have an impact on the placenta. Smoking not just during but also before pregnancy leads to epigenetic modifications (DNA methylation) which could have consequences on ...
communi

Scientists discover novel mutation associated with alternating hemiplegia of childhood

Des scientifiques du Trinity College de Dublin, de l’Inserm, d’Université Paris Cité et de l’AP-HP au sein de l'Institut Imagine à l'hôpital Necker, à Paris, viennent de découvrir un second gène responsable d'une maladie très rare appelée hémiplégie alternante de l'enfant (HAE). ...
fermer
fermer
RSS Youtube